Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis

被引：0
|
作者：
Choi, Yong Won [1 ]
Cha, Hyun-Young [1 ]
Park, Tae Jun [1 ]
Ahn, Mi Sun [1 ]
Lee, Hyun Woo [1 ]
Jeong, Seong Hyun [1 ]
Kang, Seok Yun [1 ]
Park, Joon Seong [1 ]
Choi, Jin-Hyuk [1 ]
机构：
[1] Ajou Univ, Sch Med, Suwon, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-469
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
469
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis
    Hayashi, Masataka
    Ikenaga, Naoki
    Nakata, Kohei
    Luo, Haizhen
    Zhong, PingShan
    Date, Satomi
    Oyama, Koki
    Higashijima, Nobuhiro
    Kubo, Akihiro
    Iwamoto, Chika
    Torata, Nobuhiro
    Abe, Toshiya
    Yamada, Yutaka
    Ohuchida, Kenoki
    Oda, Yoshinao
    Nakamura, Masafumi
    CANCER SCIENCE, 2023, 114 (09) : 3666 - 3678
  • [42] Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines
    Zhang, Rihua
    Pan, Xiaolin
    Huang, Zuhu
    Weber, Georg F.
    Zhang, Guoxin
    PLOS ONE, 2011, 6 (08):
  • [43] The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
    Ruffini, Pier Adelchi
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [44] Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
    Gulhati, Pat
    Schalck, Aislyn
    Jiang, Shan
    Shang, Xiaoying
    Wu, Chang-Jiun
    Hou, Pingping
    Ruiz, Sharia Hernandez
    Soto, Luisa Solis
    Parra, Edwin
    Ying, Haoqiang
    Han, Jincheng
    Dey, Prasenjit
    Li, Jun
    Deng, Pingna
    Sei, Emi
    Maeda, Dean Y.
    Zebala, John A.
    Spring, Denise J.
    Kim, Michael
    Wang, Huamin
    Maitra, Anirban
    Moore, Dirk
    Clise-Dwyer, Karen
    Wang, Y. Alan
    Navin, Nicholas E.
    DePinho, Ronald A.
    NATURE CANCER, 2023, 4 (01) : 62 - +
  • [45] Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
    Pat Gulhati
    Aislyn Schalck
    Shan Jiang
    Xiaoying Shang
    Chang-Jiun Wu
    Pingping Hou
    Sharia Hernandez Ruiz
    Luisa Solis Soto
    Edwin Parra
    Haoqiang Ying
    Jincheng Han
    Prasenjit Dey
    Jun Li
    Pingna Deng
    Emi Sei
    Dean Y. Maeda
    John A. Zebala
    Denise J. Spring
    Michael Kim
    Huamin Wang
    Anirban Maitra
    Dirk Moore
    Karen Clise-Dwyer
    Y. Alan Wang
    Nicholas E. Navin
    Ronald A. DePinho
    Nature Cancer, 2023, 4 : 62 - 80
  • [46] A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer - First analysis
    Schott, Anne F.
    Wicha, Max S.
    Perez, Raymond P.
    Kato, Giraldo
    Avery, Tiffany
    Cristofanilli, Massimo
    Reuben, James M.
    Alpaugh, R. Katherine
    McCanna, Susan
    Ruffini, Pier Adelchi
    Goldstein, Lori J.
    CANCER RESEARCH, 2015, 75
  • [47] Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer
    Zhou, Jianbo
    Wan, Feng
    Xiao, Bin
    Li, Xin
    Peng, Cheng
    Peng, Fu
    ONCOLOGY RESEARCH, 2024, 32 (05) : 943 - 953
  • [48] Reparixin, CXCR1/2 inhibitor in combination with CDK4/6 inhibitors attenuates endocrine resistant breast cancer growth and metastasis
    Pandithar, Sneha
    Reff, Olivia
    Jin, Kideok
    CANCER RESEARCH, 2022, 82 (12)
  • [49] DIF-1 exhibits anticancer activity in breast cancer via inhibition of CXCLs/CXCR2 axis-mediated communication between cancer-associated fibroblasts and cancer cells
    -Tetsuo, Fumi Seto
    Arioka, Masaki
    Miura, Koichi
    Inoue, Takeru
    Igawa, Kazunobu
    Tomooka, Katsuhiko
    Sasaguri, Toshiyuki
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [50] Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer
    Lee, Chia-Huei
    Syu, Shih-Han
    Liu, Ko-Jiunn
    Chu, Pei-Yi
    Yang, Wen-Chan
    Lin, Pinpin
    Shieh, Wan-Yu
    ONCOTARGET, 2015, 6 (36) : 38866 - 38880
12345